Incubation of L929 cells with three different glucocorticoids, hydrocortisone, dexamethasone and triamcinolone acetonide, rendered the cells unable to support plaque formation by several unrelated DNA and RNA viruses. The establishment of this antiviral state by dexamethasone coincided with an inhibition of cell growth and induction of glutamine synthetase activity. These steroid-mediated activities occurred only in cultures of L929 cells and not in cultures of rabbit skin or rat glioma cells.
responsiveness or receptor activity of the host cells to the glucocorticoid effects, or the lack thereof, on viral metabolism (Notter & Docherty, 1978; Wainberg et al., 1982) .
This communication presents evidence that glucocorticoid treatment of L929 cells renders these cells refractory to virus plaque formation. The development of this refractory state coincides with a glucocorticoid-mediated induction of glutamine synthetase activity and an inhibition of cell growth. Both of these are previously characterized glucocorticoid-mediated effects on L929 cells (Ruhmann & Berliner, 1965; Hackney et al., 1981) . Other cell lines that are unresponsive to these glucocorticoid-induced biological effects also fail to establish a state of viral refractoriness.
Confluent cell cultures were cultivated in 25 cm 2 flasks (37 °C) as described by Smith & Lancz (1982) Plaque development in L929 cells but not in rabbit skin (RS) or rat glioma (C6) cells was reduced relative to solvent-treated control cell cultures (Table 1) . Progesterone, a nonglucocorticoid steroid, was on the average only 50~, as effective as the glucocorticoids, and epicortisol, the 1 I-or-hydroxyl stereoisomer of hydrocortisone, was without biological activity. The refractory state that developed was non-specific in that it reduced plaque formation by DNA and RNA viruses. Dose-response curves for the three biologically active glucocorticoids indicated 50~ plaque reduction was achieved with 3 × 10 -6 M-hydrocortisone, 10 -7 Mdexamethasone and 10 -8 M-triamcinolone acetonide (Fig. 1) .
The glucocorticoid responsiveness of the three cell lines was examined further. Haemocytometer counts indicated dexamethasone treatment of subconfluent cell cultures for 72 h inhibited the growth of L929 cells but not RS cells ( Effect of 10 gM-dexamethasone treatment on glutamine synthetase activity in cell Cell line L929 C6 RS * Nanomoles y-glutamohydroxamate formed/mg protein/h. Assayed for glutamine synthetase activity as described by Kirk (1965) .
t Mean value ± S.E.M.
cultures for 72 h with dexamethasone did not result in visible toxic effects or in a significant loss of cells in the culture (Table 2) . Furthermore, glutamine synthetase activity following incubation with dexamethasone for 72 h was significantly elevated in L929 cells, only slightly elevated in C6 cells and unchanged in RS cells (Table 3) . Additional studies indicated dexamethasone did not directly inactive the challenge virus (Notter & Docherty, 1978; G. J. Lancz & B. A. Hulick, unpublished observations) and that dexamethasone treatment of L929 cells resulted in a decreased virus yield (G. J. Lancz & B. A. Hulick, unpublished observations). Thus, the inhibition of virus plaque formation likely reflects an inhibition of virus replication and not an inhibition of cell-to-cell spread of the virus. Collectively, the data indicated three coincident biological activities in dexamethasone-treated L929 cells: induction of glutamine synthetase activity, growth inhibition of cells and development of a state that rendered the cells refractory to virus replication.
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